Search

everythinglearnresearchcommunity

for

Search:↓

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

Panax ginseng is generally safe with mild side effects and may have health benefits, but more research is needed.

Many COVID-19 survivors experience long-lasting symptoms, including hair loss and psychological issues.

Quercetin may help with PCOS symptoms, but more research is needed.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Teledermatology became a valuable and convenient tool for skin care during the COVID-19 pandemic.

Clindamycin and rifampicin are the most effective treatments for folliculitis decalvans, but more research is needed.

Dutasteride more effectively treats hair loss than finasteride, but may increase risk of altered libido.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Vertex pattern hair loss linked to higher prostate cancer risk.

5-alpha reductase inhibitors are generally safe but can cause sexual side effects and require patient education on risks.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Hair transplantation may work for some types of scarring alopecia, but results vary and more research is needed.

Thallium, mercury, selenium, and colchicine strongly cause hair loss.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

COVID-19 can cause a type of hair loss that usually starts 74 days after infection, affecting mostly women, but most patients eventually recover.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

Some treatments like pentoxifylline with topical corticosteroids might work for alopecia areata, but more research is needed to find the best one.

Topical finasteride reduces hair loss and promotes hair growth in men and women.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.